We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.775 | 0.75 | 0.80 | 0.775 | 0.75 | 0.75 | 274,906 | 08:00:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.52 | 2.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/4/2020 16:41 | that site is a bit weird. If Evgen are looking at it, why don't they say so? It would give the share price a boost. I wonder if they tendered for some of the LifeArc grant? They should also talk to the government about the RECOVERY trial, maybe they are but it would be nice to know. | davemac3 | |
16/4/2020 13:47 | Personally no, but they have collaboration agreements with Universities of Manchester and also Rochester for development of Sulforaphane based medicines, and both Universities are now heavily involved in Covid-19 research if you check out their websites, and so it stands to reason that they might be working with EVG on potential treatments since Sulforaphane has been highlighted as a possible therapy compound. Gl :-) | moneymunch | |
16/4/2020 13:36 | does anybody know whether Evgen are looking at Sulforaphane as a Covid-19 treatment? | davemac3 | |
16/4/2020 13:16 | If this story gets picked up by the weekend press then Monday could be 5th of November all over again ! | mesquida | |
16/4/2020 13:05 | managed 17000shares at about 10p after trying at length 9.50 with ii | the patient investor | |
16/4/2020 13:01 | Looking good for news.Gla :-) | moneymunch | |
16/4/2020 12:54 | I've tried to have a little top and yeah and NT so left it as not comfortable with not getting a fixed quote as it'll be dealing for a while and then execute at the day's high two hours later! | tickboo | |
16/4/2020 12:45 | Again the MMs won't let you buy even 1000 shares online! This is not a fair playing field. You get the feeling that they are caught and short and don't want to push it up any further until their book is filled.... | nobbygnome | |
16/4/2020 10:50 | Based on the finding that NRF2 activation slows down HSV-1 infection, the researchers tested the effectiveness of two drugs, Bardoxolone methyl and Sulforaphane, that are known to activate the NRF2 pathway, in preventing an HSV-1 infection from taking place. They found that when cells were treated with these NRF2 agonists, the virus activated fewer of its own genes and consequentially virus production was impaired. This suggested that NRF2 activation restricts viral infection. These results suggest a potential opportunity to prevent HSV infection in those with low immune systems. However, the researchers don't intend to stop there, with plans already in place to use the same method to investigate another type of herpes virus and coronaviruses. | davemac3 | |
15/4/2020 14:10 | Watch SAR: recent tweet https://twitter.com/ | spqstrader | |
15/4/2020 13:56 | Sounds promising Full video ARS, DISH, DEV, EVG, GDR, GLR, N4P, NCYT, ORPH, TILS @ZaksTradersCafehttp | tickboo | |
15/4/2020 13:52 | any ideas on cash n debt level. tia | latifs100 | |
15/4/2020 13:38 | Dr Meng continued: “Our findings show that timed administration of the antioxidant compound sulforaphane, effectively attenuates the severity of the lung fibrosis in this mouse model.” .................... | moneymunch | |
15/4/2020 13:31 | Dow futures not so good at -416 right now. Pharma's should stay bright enough whatever:) | bmnsa | |
15/4/2020 13:28 | Well there seems to be a general concensus that sulforaphane based medicines could be beneficial in the fight against Covid, and so any update from EVG along those lines could see this fly. They have collaboration agreements with the University of Rochester and University of Manchester in developing sulforaphane based medicines for the treatment of multiple diseases, and both Universities are now heavily involved in Covid-19 research and development, and so watch this space. Gla ;-) | moneymunch | |
15/4/2020 13:10 | Well let's hope the gap at 15p goes in the coming days. | tickboo | |
15/4/2020 13:02 | 15p is where I got in! S will just be relieved if it gets back and then past | toffeeman | |
15/4/2020 12:45 | There's a gap up to around 15p which could well be filled now..... | nobbygnome | |
15/4/2020 12:45 | offering 75k at 10.25p | euclid5 | |
15/4/2020 12:41 | Nice move up | trinitygooner | |
15/4/2020 12:24 | Nope still can't get a quote for 1000 shares even now they have moved to 9p. | nobbygnome | |
15/4/2020 12:19 | Still can't even buy 1000 shares on line. FFS the clue is in the name,they are supposed to make a market! | nobbygnome | |
15/4/2020 12:14 | Who knows? But we now have backwardation which just proves it. Peel now bidding 8.8p. | nobbygnome | |
15/4/2020 12:12 | Why are they holding it back? | herb clark |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions